Cite
HARVARD Citation
Dartigeas, C. et al. (2018). Rituximab maintenance versus observation following abbreviated induction with chemoimmunotherapy in elderly patients with previously untreated chronic lymphocytic leukaemia (CLL 2007 SA): an open-label, randomised phase 3 study. Lancet. 5 (2), pp. e82-e94. [Online].